Oral Contraceptives Vs. Ovarian Cancer

March 1999
Joe Weider's Muscle & Fitness;Mar99, Vol. 60 Issue 3, p38
Reveals that researchers may have determined how oral contraceptives help protect against ovarian cancer. Number of American women died from the disease annually; Information on progestin, a component of birth-control pills that triggers the death of ovarian cells with genetic abnormalities.


Related Articles

  • High-progestin OCs offer better protection against ovarian Ca. Schildkraut, J. M.; Calingaert, B.; MarchbanKs, P. A. // Contemporary OB/GYN;Jun2002, Vol. 47 Issue 6, p24 

    Reports on the protection offered by oral contraceptives (OC) against ovarian cancer, according to a study involving women between 20 and 54 years of age. Advantage of OC formulations with greater progestin potency over low-progestin formulations; Function of progestin that activates protection...

  • Pill power. Holmes, Bob // New Scientist;09/19/98, Vol. 159 Issue 2152, p10 

    Reports on a hormone used in oral contraceptives which may protect against ovarian cancer. Experiments on monkeys conducted by researcher Gustavo Rodriquez of Duke University Medical Center in Durham, North Carolina; Use of synthetic progestin in macaque monkeys which triggered programmed cell...

  • CHAPTER 12: OB/GYN.  // Monthly Prescribing Reference;Oct2015, Vol. 31 Issue 10, p200 

    The article offers brief information on the contraceptives indicated for obstetrics and gynecology from several pharmaceutical companies including Depo-Provera Cl from Pfizer Inc., Ella from Afaxys Inc. and Mirena from Bayer AG.

  • Effects of Progestogens and OCs on Nerve Fibers.  // Fertility Weekly;11/16/2009, p6 

    The article reports on a study concerning the effects of progestogens and oral contraceptives (OCs) on the human nerve fibers. It examines the way progestogens and combined OCs change the nerve fiber density in peritoneal endometriotic lesions, as well as determine the types of nerve fibers that...

  • actions in brief.  // Formulary;Mar2007, Vol. 42 Issue 3, p148 

    The article reports on the approval of new drugs by the U.S. Food and Drug Administration. Drospirenone/20 mcg ethinyl estradiol has been approved for the treatment of moderate acne vulgaris in women who desire an oral contraceptive for birth control. Azacitidine was approved for intravenous...

  • Contraception guidance for postpartum period.  // Contraceptive Technology Update;Sep2011, Vol. 32 Issue 9, p101 

    The article reports on guidelines on contraception for women in the postpartum period which were released in 2011 by the U.S. Centers for Disease Control and Prevention.

  • Oral contraceptives: What you need to know about the latest formulations. MICKS, ELIZABETH; JENSEN, JEFFREY T. // Contemporary OB/GYN;Feb2012, Vol. 57 Issue 2, p43 

    The article offers information on developments in oral contraceptives (OCs) that are currently available, including new dose regimens of estrogens and progestins. The fourth-generation progestins include drospirenone, dienogest and nestorone and estradiol based pills include estradiol valerate....

  • Can the pill reduce the risk of ovarian cancer? Begany, Timothy // RN;Jan95, Vol. 58 Issue 1, p15 

    Reports on the effects of oral contraceptives (OC) on women with ovarian cancer. Hereditary predisposition; Reduction in cancer risk with prolonged OC use; Prevention of ovarian cancer in women with predisposition.

  • Preventive pill?  // Joe Weider's Muscle & Fitness;Nov94, Vol. 55 Issue 11, p42 

    Reports on a study published in The journal of `Obstetrics & Gynecology' which states that the birth control pill might help prevent epithelial ovarian cancer.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics